|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Available-for-sale marketable securities | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Restricted cash | ||||||||||
| Property and equipment, net | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Finance lease right-of-use assets | ||||||||||
| Other non-current assets | ||||||||||
| Total assets | ||||||||||
| Liabilities, and stockholders' equity | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | ||||||||||
| Accrued compensation | ||||||||||
| Accrued license expense - related party | ||||||||||
| Other accrued expenses and current liabilities | ||||||||||
| Operating lease liabilities, short-term portion | ||||||||||
| Finance lease liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Operating lease liabilities, net of short-term portion | ||||||||||
| Finance lease liabilities, net of short-term portion | ||||||||||
| Other non-current liabilities | ||||||||||
| Term loan | ||||||||||
| Total liabilities | ||||||||||
| Redeemable convertible preferred stock, no par value; no shares authorized, issued and outstanding as of December 31, 2024 $0.00001 par value 114,556,997 shares authorized as of December 31, 2023; 114,556,997 shares issued and outstanding as of December 31, 2023; liquidation preference of $181,273 as of December 31, 2023 | ||||||||||
| Stockholders' equity | ||||||||||
| Preferred stock, 10,000,000 shares authorized, $0.00001 par value, no shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||
| Common stock, $0.00001 par value; 490,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 61,570,247 and 60,389,893 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...
